Author:
Pham Trang Thanh,Liney Gary,Wong Karen,Rai Robba,Lee Mark,Moses Daniel,Henderson Christopher,Lin Michael,Shin Joo-Shik,Barton Michael Bernard
Funder
Royal Australian and New Zealand College of Radiologists (RANZCR)
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Oncology
Reference18 articles.
1. Sauer R, Liersch T, Merkel S, Fietkau R, Hohenberger W, Hess C, Becker H, Raab HR, Villanueva MT, Witzigmann H, et al. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years. J Clin Oncol. 2012;30(16):1926–33.
2. National Comprehensive Cancer Network (NNCN): NCCN Clinical Practice Guidelines in Oncology Rectal Cancer Version 3.2015. 2015.
3. National Institute for Health and Care Excellence (NICE): Colorectal cancer the diagnosis and management of colorectal cancer. NICE clinical guideline 131 2014.
4. Maas M, Nelemans PJ, Valentini V, Das P, Rödel C, Kuo L-J, Calvo FA, García-Aguilar J, Glynne-Jones R, Haustermans K, et al. Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. Lancet Oncol. 2010;11(9):835–44.
5. Valentini V, Coco C, Cellini N, Picciocchi A, Fares MC, Rosetto ME, Mantini G, Morganti AG, Barbaro B, Cogliandolo S, et al. Ten years of preoperative chemoradiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, and sphincter preservation in three consecutive studies. Int J Radiat Oncol Biol Phys. 2001;51(2):371–83.